Design Therapeutics Inc (DSGN)
5.00
+0.28
(+5.93%)
USD |
NASDAQ |
Oct 04, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Design Therapeutics Shareholders Equity (Annual): 277.69M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 277.69M |
| December 31, 2022 | 327.31M |
| December 31, 2021 | 382.13M |
| Date | Value |
|---|---|
| December 31, 2020 | -11.32M |
| December 31, 2019 | -3.642M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-11.32M
Minimum
2020
382.13M
Maximum
2021
194.43M
Average
277.69M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Biogen Inc | 14.80B |
| PTC Therapeutics Inc | -818.56M |
| Voyager Therapeutics Inc | 236.32M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |